OutSee raises £1.8M to expand therapeutic pipeline using predictive genomics

▤ Summary

OutSee raised £1.8 million in seed funding to expand its predictive genomics platform and grow its therapeutic discovery pipeline. The company uses its Nomaly technology to analyze genomic data and uncover disease targets from small or previously analyzed datasets. The funding will support internal target discovery work and help OutSee form partnerships with pharmaceutical and biotech companies. The company also signaled that it remains open to additional investment and industry collaboration.

$ Funding

▦ Linked Companies